CTRI/2017/09/009939已完成4 期
A retrospective, single-center, study to evaluate safety and performance of the Evermine 50- 50μm Everolimus Eluting Coronary Stent System (EES) in the treatment of patients with de novo coronary artery lesions.
Meril Life Sciences Pvt Ltd0 个研究点目标入组 171 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 171
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Pms
入排标准
入选标准
- •1. All patients who have been treated with Evermine 50 EES.
- •2. Patients who are contactable, willing to participate will be taken into the study by either signing voluntary informed consent form or by taking telephonic consent of patient.
排除标准
- •1. There are no exclusion criteria for this study.
研究者
相似试验
尚未招募
不适用
A prospective, single-centre study to investigate the role of Optical Coherence Tomography and fractional flow reserve for post coronary angioplasty stent optimisatioCTRI/2021/04/032543PGIMER
尚未招募
Unknown
A prospective, Single-Centre study to investigate the plaque characteristics of lesions in young Indian patients of =40 yearsCTRI/2024/01/061165Dr Nityanand Tripathi
进行中（未招募）
不适用
GONDOLA: Gonorrhoea detection using laboratory assessmentGonococcal infectionInfections and InfestationsISRCTN16307168orth Cumbria University Hospitals NHS Trust60
招募中
不适用
sefulness of acetic acid NBI magnification endoscopy for colorectal tumorsJPRN-UMIN000045621Sendai City Medical Center Sendai Open Hospital Department of Gastroenterology300
已完成
不适用
Retrospective monocentric cohort study to evaluate the efficacy and safety of Splentis for transvaginal sacrospinal fixation of the primary apical prolapseN81.4Uterovaginal prolapse, unspecifiedDRKS00021072Promedon GmbH110